MSB 2.45% 99.5¢ mesoblast limited

Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-5

  1. 951 Posts.
    lightbulb Created with Sketch. 136
    ann ....yea in this market ...clutching at straws ...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.